Richard Jackson
Concepts (496)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Biosynthesis | 20 | 2012 | 258 | 3.120 |
Why?
| | RNA, Viral | 15 | 2013 | 127 | 2.530 |
Why?
| | Ribosomes | 14 | 2013 | 33 | 1.770 |
Why?
| | Public Health | 8 | 2024 | 223 | 1.670 |
Why?
| | RNA, Messenger | 10 | 2014 | 1132 | 1.390 |
Why?
| | Peptide Chain Initiation, Translational | 10 | 2013 | 15 | 1.380 |
Why?
| | Polypyrimidine Tract-Binding Protein | 7 | 2014 | 11 | 1.370 |
Why?
| | Environment Design | 8 | 2024 | 26 | 1.120 |
Why?
| | Rhinovirus | 3 | 2010 | 24 | 0.840 |
Why?
| | Nucleic Acid Conformation | 14 | 2013 | 85 | 0.840 |
Why?
| | Public Policy | 3 | 2015 | 38 | 0.770 |
Why?
| | Environmental Health | 3 | 2011 | 14 | 0.680 |
Why?
| | RNA-Binding Proteins | 5 | 2012 | 128 | 0.620 |
Why?
| | 5' Untranslated Regions | 5 | 2011 | 30 | 0.610 |
Why?
| | Environment | 2 | 2011 | 89 | 0.600 |
Why?
| | City Planning | 5 | 2009 | 6 | 0.600 |
Why?
| | Ligaments | 1 | 2017 | 11 | 0.580 |
Why?
| | Ribs | 1 | 2017 | 16 | 0.570 |
Why?
| | Binding Sites | 10 | 2014 | 377 | 0.560 |
Why?
| | Chest Pain | 1 | 2017 | 57 | 0.560 |
Why?
| | Humans | 70 | 2025 | 52483 | 0.550 |
Why?
| | Gene Expression Regulation | 4 | 2011 | 990 | 0.540 |
Why?
| | Vinblastine | 1 | 2017 | 23 | 0.540 |
Why?
| | Peptide Chain Termination, Translational | 4 | 2011 | 4 | 0.540 |
Why?
| | MicroRNAs | 4 | 2011 | 387 | 0.530 |
Why?
| | Base Sequence | 14 | 2011 | 640 | 0.530 |
Why?
| | Pancreatic Neoplasms | 3 | 2025 | 216 | 0.520 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2017 | 71 | 0.520 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2017 | 54 | 0.510 |
Why?
| | Molecular Sequence Data | 13 | 2011 | 778 | 0.500 |
Why?
| | Encephalomyocarditis virus | 3 | 2011 | 3 | 0.500 |
Why?
| | Renewable Energy | 1 | 2015 | 2 | 0.480 |
Why?
| | Vertebrates | 2 | 2013 | 11 | 0.480 |
Why?
| | Biofuels | 1 | 2015 | 6 | 0.480 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2017 | 165 | 0.470 |
Why?
| | Picornaviridae | 2 | 2011 | 2 | 0.460 |
Why?
| | DNA-Binding Proteins | 3 | 2007 | 422 | 0.460 |
Why?
| | Eukaryotic Cells | 2 | 2012 | 15 | 0.450 |
Why?
| | Public Health Administration | 2 | 2012 | 81 | 0.420 |
Why?
| | Open Reading Frames | 5 | 2012 | 55 | 0.420 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2025 | 40 | 0.420 |
Why?
| | Viral Proteins | 4 | 2009 | 164 | 0.410 |
Why?
| | Eukaryotic Initiation Factors | 2 | 2010 | 5 | 0.410 |
Why?
| | Eukaryotic Initiation Factor-4G | 2 | 2010 | 5 | 0.400 |
Why?
| | Pestivirus | 2 | 2002 | 2 | 0.400 |
Why?
| | Poliovirus | 2 | 2010 | 10 | 0.400 |
Why?
| | Health Policy | 2 | 2024 | 158 | 0.380 |
Why?
| | Codon, Initiator | 7 | 2011 | 9 | 0.380 |
Why?
| | Foot-and-Mouth Disease Virus | 1 | 2011 | 2 | 0.370 |
Why?
| | Social Environment | 2 | 2012 | 81 | 0.370 |
Why?
| | Environmental Exposure | 2 | 2002 | 216 | 0.330 |
Why?
| | Eukaryota | 1 | 2010 | 10 | 0.330 |
Why?
| | Obesity | 2 | 2011 | 1162 | 0.320 |
Why?
| | Virus Replication | 1 | 2010 | 150 | 0.310 |
Why?
| | Residence Characteristics | 2 | 2024 | 159 | 0.300 |
Why?
| | Social Conditions | 1 | 2008 | 8 | 0.290 |
Why?
| | Calicivirus, Feline | 1 | 2007 | 2 | 0.290 |
Why?
| | Models, Genetic | 2 | 2007 | 169 | 0.290 |
Why?
| | RNA Caps | 1 | 2007 | 5 | 0.280 |
Why?
| | Animals | 20 | 2013 | 13505 | 0.280 |
Why?
| | Research | 2 | 2005 | 107 | 0.270 |
Why?
| | Adolescent | 15 | 2017 | 6739 | 0.270 |
Why?
| | Life Style | 1 | 2008 | 145 | 0.270 |
Why?
| | Peptic Ulcer Perforation | 1 | 2006 | 4 | 0.270 |
Why?
| | Child | 21 | 2024 | 7248 | 0.270 |
Why?
| | Abdomen, Acute | 1 | 2006 | 6 | 0.270 |
Why?
| | Urban Health | 2 | 2003 | 31 | 0.270 |
Why?
| | Stomach Ulcer | 1 | 2006 | 7 | 0.270 |
Why?
| | United States | 11 | 2015 | 5192 | 0.260 |
Why?
| | Community Health Planning | 2 | 2003 | 28 | 0.260 |
Why?
| | Gastroenteritis | 1 | 2006 | 19 | 0.260 |
Why?
| | Protein Structure, Tertiary | 4 | 2014 | 242 | 0.260 |
Why?
| | Health Promotion | 4 | 2013 | 270 | 0.260 |
Why?
| | Gastrointestinal Diseases | 2 | 2008 | 125 | 0.260 |
Why?
| | Child Welfare | 2 | 2007 | 53 | 0.260 |
Why?
| | Eosinophilia | 1 | 2006 | 36 | 0.250 |
Why?
| | Early Detection of Cancer | 2 | 2025 | 189 | 0.250 |
Why?
| | Bacterial Translocation | 4 | 2009 | 15 | 0.240 |
Why?
| | Health Priorities | 2 | 2024 | 19 | 0.240 |
Why?
| | Genes, Neurofibromatosis 1 | 1 | 2005 | 3 | 0.240 |
Why?
| | Neurofibromatoses | 1 | 2005 | 6 | 0.240 |
Why?
| | Mental Health | 1 | 2008 | 240 | 0.240 |
Why?
| | Laparoscopy | 4 | 2013 | 180 | 0.240 |
Why?
| | Transcription, Genetic | 3 | 2003 | 378 | 0.230 |
Why?
| | Nerve Sheath Neoplasms | 1 | 2005 | 25 | 0.230 |
Why?
| | Female | 27 | 2025 | 28171 | 0.230 |
Why?
| | Pregnancy, Twin | 1 | 2024 | 8 | 0.230 |
Why?
| | Male | 27 | 2025 | 26761 | 0.230 |
Why?
| | Probiotics | 3 | 2009 | 24 | 0.230 |
Why?
| | Rectal Neoplasms | 1 | 2005 | 53 | 0.230 |
Why?
| | Pancreatitis | 1 | 2025 | 64 | 0.220 |
Why?
| | Fetal Growth Retardation | 1 | 2024 | 40 | 0.220 |
Why?
| | Mammals | 3 | 2010 | 61 | 0.220 |
Why?
| | Child, Preschool | 14 | 2017 | 4076 | 0.220 |
Why?
| | Rain | 1 | 2003 | 5 | 0.210 |
Why?
| | Climate Change | 1 | 2024 | 53 | 0.210 |
Why?
| | Water Pollutants | 1 | 2003 | 8 | 0.210 |
Why?
| | Water Supply | 1 | 2003 | 22 | 0.210 |
Why?
| | Water Microbiology | 1 | 2003 | 31 | 0.210 |
Why?
| | Feasibility Studies | 2 | 2024 | 406 | 0.210 |
Why?
| | Public Health Practice | 1 | 2003 | 42 | 0.210 |
Why?
| | Environmental Pollution | 2 | 2003 | 14 | 0.210 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2002 | 7 | 0.200 |
Why?
| | Retrospective Studies | 13 | 2017 | 6607 | 0.200 |
Why?
| | Cryogels | 1 | 2022 | 1 | 0.200 |
Why?
| | Models, Econometric | 1 | 2002 | 13 | 0.200 |
Why?
| | Lead | 1 | 2002 | 33 | 0.190 |
Why?
| | Goiter, Endemic | 1 | 2002 | 1 | 0.190 |
Why?
| | Nuclear Reactors | 1 | 2002 | 2 | 0.190 |
Why?
| | Exercise | 2 | 2015 | 547 | 0.190 |
Why?
| | Radioactive Hazard Release | 1 | 2002 | 14 | 0.190 |
Why?
| | Iodine | 1 | 2002 | 12 | 0.190 |
Why?
| | Genetic Predisposition to Disease | 1 | 2005 | 528 | 0.190 |
Why?
| | Rectum | 2 | 2017 | 55 | 0.190 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2002 | 37 | 0.190 |
Why?
| | Sodium Chloride, Dietary | 1 | 2002 | 34 | 0.190 |
Why?
| | Income | 1 | 2002 | 102 | 0.190 |
Why?
| | Disaster Planning | 1 | 2002 | 35 | 0.180 |
Why?
| | Fundoplication | 2 | 2013 | 20 | 0.180 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 595 | 0.180 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2021 | 51 | 0.180 |
Why?
| | Biomedical Research | 1 | 2024 | 256 | 0.180 |
Why?
| | Hyperthermia, Induced | 1 | 2022 | 120 | 0.180 |
Why?
| | Cognition Disorders | 1 | 2002 | 196 | 0.180 |
Why?
| | Computer Simulation | 1 | 2021 | 290 | 0.170 |
Why?
| | Treatment Outcome | 11 | 2021 | 5422 | 0.170 |
Why?
| | Models, Molecular | 3 | 2012 | 348 | 0.170 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2021 | 121 | 0.170 |
Why?
| | Influenza B virus | 2 | 2011 | 6 | 0.170 |
Why?
| | Infant | 13 | 2017 | 3733 | 0.160 |
Why?
| | Reticulocytes | 3 | 2011 | 9 | 0.160 |
Why?
| | Cohort Studies | 7 | 2022 | 1542 | 0.160 |
Why?
| | Rabbits | 7 | 2011 | 375 | 0.160 |
Why?
| | Codon | 2 | 2010 | 43 | 0.160 |
Why?
| | Endovascular Procedures | 1 | 2021 | 178 | 0.150 |
Why?
| | Genome, Viral | 2 | 2011 | 83 | 0.150 |
Why?
| | Pyloric Stenosis | 2 | 2009 | 6 | 0.150 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 316 | 0.150 |
Why?
| | Infant, Newborn | 9 | 2024 | 2867 | 0.150 |
Why?
| | Sequence Alignment | 2 | 2009 | 125 | 0.140 |
Why?
| | Amino Acid Sequence | 3 | 2009 | 578 | 0.140 |
Why?
| | Ireland | 1 | 2017 | 14 | 0.140 |
Why?
| | Vagina | 1 | 2017 | 46 | 0.140 |
Why?
| | Prospective Studies | 6 | 2025 | 2481 | 0.130 |
Why?
| | Urothelium | 1 | 2017 | 19 | 0.130 |
Why?
| | Syndrome | 1 | 2017 | 247 | 0.130 |
Why?
| | Lasers, Solid-State | 1 | 2017 | 32 | 0.130 |
Why?
| | Alternative Splicing | 2 | 2014 | 62 | 0.130 |
Why?
| | Middle Aged | 7 | 2025 | 13028 | 0.130 |
Why?
| | Walking | 2 | 2015 | 104 | 0.130 |
Why?
| | Adult | 10 | 2025 | 14161 | 0.130 |
Why?
| | Wounds, Nonpenetrating | 2 | 2008 | 83 | 0.130 |
Why?
| | Aged | 6 | 2024 | 10121 | 0.130 |
Why?
| | Endosonography | 2 | 2025 | 98 | 0.120 |
Why?
| | Disease-Free Survival | 1 | 2017 | 460 | 0.120 |
Why?
| | Food, Formulated | 2 | 2008 | 42 | 0.120 |
Why?
| | Vascular Malformations | 1 | 2017 | 103 | 0.120 |
Why?
| | Breast Neoplasms | 1 | 2024 | 1212 | 0.120 |
Why?
| | Catheterization | 2 | 2008 | 96 | 0.120 |
Why?
| | Public Opinion | 1 | 2015 | 21 | 0.120 |
Why?
| | Bicycling | 1 | 2015 | 28 | 0.120 |
Why?
| | Postoperative Complications | 4 | 2021 | 1068 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2017 | 184 | 0.110 |
Why?
| | RNA Precursors | 1 | 2014 | 9 | 0.110 |
Why?
| | Lung | 2 | 2009 | 509 | 0.110 |
Why?
| | Codon, Terminator | 3 | 2009 | 8 | 0.110 |
Why?
| | Gastric Fistula | 1 | 2013 | 10 | 0.110 |
Why?
| | Enteral Nutrition | 3 | 2008 | 154 | 0.110 |
Why?
| | Cutaneous Fistula | 1 | 2013 | 14 | 0.110 |
Why?
| | Gastric Mucosa | 3 | 2009 | 45 | 0.110 |
Why?
| | Multicenter Studies as Topic | 2 | 2024 | 105 | 0.110 |
Why?
| | Gastrostomy | 1 | 2013 | 58 | 0.100 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2004 | 95 | 0.100 |
Why?
| | Peptide Initiation Factors | 1 | 2013 | 3 | 0.100 |
Why?
| | HeLa Cells | 3 | 2010 | 265 | 0.100 |
Why?
| | Communication | 1 | 2015 | 257 | 0.100 |
Why?
| | Liver Neoplasms | 1 | 2017 | 333 | 0.100 |
Why?
| | Animals, Newborn | 3 | 2009 | 362 | 0.100 |
Why?
| | Classical swine fever virus | 2 | 2002 | 2 | 0.100 |
Why?
| | Mutation | 4 | 2014 | 1347 | 0.100 |
Why?
| | Protein Binding | 3 | 2014 | 667 | 0.100 |
Why?
| | Mobility Limitation | 1 | 2012 | 26 | 0.100 |
Why?
| | Local Government | 1 | 2012 | 23 | 0.100 |
Why?
| | Physician's Role | 2 | 2009 | 49 | 0.090 |
Why?
| | Kobuvirus | 1 | 2011 | 2 | 0.090 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2011 | 8 | 0.090 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2011 | 8 | 0.090 |
Why?
| | Artificial Gene Fusion | 1 | 2011 | 7 | 0.090 |
Why?
| | Enterobacter cloacae | 2 | 2009 | 5 | 0.090 |
Why?
| | Stomach | 3 | 2009 | 82 | 0.090 |
Why?
| | Genes, Reporter | 1 | 2011 | 88 | 0.090 |
Why?
| | Poly A | 1 | 2011 | 10 | 0.090 |
Why?
| | Follow-Up Studies | 6 | 2017 | 2279 | 0.090 |
Why?
| | Organizational Objectives | 1 | 2011 | 35 | 0.090 |
Why?
| | Leadership | 1 | 2012 | 103 | 0.090 |
Why?
| | Quality of Life | 2 | 2021 | 879 | 0.090 |
Why?
| | Catheterization, Central Venous | 2 | 2002 | 84 | 0.090 |
Why?
| | Life Expectancy | 1 | 2011 | 34 | 0.090 |
Why?
| | Spleen | 2 | 2009 | 172 | 0.090 |
Why?
| | Kinetics | 2 | 2010 | 626 | 0.090 |
Why?
| | Base Pairing | 1 | 2010 | 27 | 0.090 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 64 | 0.090 |
Why?
| | Bromouracil | 1 | 2010 | 1 | 0.090 |
Why?
| | Pseudouridine | 1 | 2010 | 1 | 0.090 |
Why?
| | RNA, Small Interfering | 2 | 2011 | 213 | 0.090 |
Why?
| | Trinucleotide Repeats | 1 | 2010 | 4 | 0.090 |
Why?
| | Uridine Triphosphate | 1 | 2010 | 10 | 0.090 |
Why?
| | Uridine | 1 | 2010 | 5 | 0.090 |
Why?
| | Cell Extracts | 1 | 2010 | 6 | 0.090 |
Why?
| | Microtechnology | 1 | 2010 | 4 | 0.090 |
Why?
| | Laparotomy | 2 | 2008 | 37 | 0.080 |
Why?
| | Biopsy | 3 | 2009 | 605 | 0.080 |
Why?
| | Hernia, Diaphragmatic | 1 | 2010 | 22 | 0.080 |
Why?
| | Norovirus | 1 | 2009 | 3 | 0.080 |
Why?
| | Point Mutation | 1 | 2010 | 67 | 0.080 |
Why?
| | Enema | 1 | 2009 | 9 | 0.080 |
Why?
| | Meconium | 1 | 2009 | 6 | 0.080 |
Why?
| | Transportation | 2 | 2015 | 30 | 0.080 |
Why?
| | Ileus | 1 | 2009 | 14 | 0.080 |
Why?
| | Intestinal Atresia | 1 | 2009 | 5 | 0.080 |
Why?
| | Viruses | 1 | 2009 | 25 | 0.080 |
Why?
| | Food, Fortified | 1 | 2009 | 27 | 0.080 |
Why?
| | Enterobacteriaceae Infections | 1 | 2009 | 18 | 0.080 |
Why?
| | Models, Biological | 3 | 2008 | 735 | 0.080 |
Why?
| | Risk Assessment | 4 | 2008 | 1327 | 0.080 |
Why?
| | Models, Educational | 1 | 2009 | 32 | 0.080 |
Why?
| | Pyloric Stenosis, Hypertrophic | 1 | 2009 | 21 | 0.080 |
Why?
| | Health Behavior | 2 | 2015 | 257 | 0.080 |
Why?
| | Peritoneal Dialysis | 1 | 2008 | 33 | 0.070 |
Why?
| | Epithelial Cells | 1 | 2010 | 215 | 0.070 |
Why?
| | Suture Techniques | 1 | 2008 | 60 | 0.070 |
Why?
| | Snake Bites | 1 | 2008 | 14 | 0.070 |
Why?
| | Multiple Trauma | 1 | 2008 | 32 | 0.070 |
Why?
| | Equipment Contamination | 3 | 2002 | 19 | 0.070 |
Why?
| | Viral Structural Proteins | 1 | 2007 | 6 | 0.070 |
Why?
| | Genes | 1 | 2007 | 31 | 0.070 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2007 | 47 | 0.070 |
Why?
| | Robotics | 1 | 2008 | 43 | 0.070 |
Why?
| | Time Factors | 4 | 2010 | 2968 | 0.070 |
Why?
| | Cats | 1 | 2007 | 73 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2006 | 1046 | 0.070 |
Why?
| | RNA Cap Analogs | 1 | 2007 | 1 | 0.070 |
Why?
| | Pheochromocytoma | 1 | 2008 | 35 | 0.070 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2007 | 74 | 0.070 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2008 | 49 | 0.070 |
Why?
| | Telephone | 1 | 2008 | 71 | 0.070 |
Why?
| | Drosophila | 1 | 2007 | 17 | 0.070 |
Why?
| | Intestinal Obstruction | 1 | 2007 | 38 | 0.070 |
Why?
| | United States Government Agencies | 1 | 2007 | 2 | 0.070 |
Why?
| | Aftercare | 1 | 2008 | 76 | 0.070 |
Why?
| | Polymers | 2 | 2022 | 49 | 0.070 |
Why?
| | Ecology | 1 | 2007 | 18 | 0.070 |
Why?
| | Cystic Fibrosis | 1 | 2009 | 154 | 0.070 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2007 | 2 | 0.070 |
Why?
| | Enzymes, Immobilized | 1 | 2007 | 5 | 0.070 |
Why?
| | Disulfides | 1 | 2007 | 17 | 0.070 |
Why?
| | Aging | 1 | 2012 | 701 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 1678 | 0.070 |
Why?
| | Surgical Procedures, Operative | 1 | 2008 | 64 | 0.070 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2010 | 295 | 0.070 |
Why?
| | RNA Stability | 1 | 2007 | 25 | 0.070 |
Why?
| | Biosensing Techniques | 1 | 2007 | 30 | 0.070 |
Why?
| | Cell Line | 3 | 2008 | 1030 | 0.070 |
Why?
| | Hemodynamics | 1 | 2008 | 263 | 0.070 |
Why?
| | Duodenum | 1 | 2006 | 34 | 0.070 |
Why?
| | Aorta, Abdominal | 1 | 2006 | 39 | 0.070 |
Why?
| | Abdominal Injuries | 1 | 2006 | 36 | 0.070 |
Why?
| | Lipoma | 1 | 2006 | 18 | 0.060 |
Why?
| | Glycoproteins | 1 | 2007 | 122 | 0.060 |
Why?
| | Caenorhabditis elegans | 1 | 2007 | 139 | 0.060 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2006 | 76 | 0.060 |
Why?
| | Arterial Occlusive Diseases | 1 | 2006 | 79 | 0.060 |
Why?
| | RNA, Ribosomal, 18S | 3 | 2011 | 7 | 0.060 |
Why?
| | Curriculum | 1 | 2009 | 398 | 0.060 |
Why?
| | Gold | 1 | 2007 | 128 | 0.060 |
Why?
| | Registries | 2 | 2025 | 581 | 0.060 |
Why?
| | Clinical Competence | 1 | 2009 | 406 | 0.060 |
Why?
| | Down-Regulation | 1 | 2007 | 346 | 0.060 |
Why?
| | Liver | 2 | 2009 | 1156 | 0.060 |
Why?
| | Mesenchymoma | 1 | 2005 | 3 | 0.060 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2005 | 5 | 0.060 |
Why?
| | Rhabdomyosarcoma | 1 | 2005 | 13 | 0.060 |
Why?
| | Pancreatitis, Chronic | 1 | 2025 | 11 | 0.060 |
Why?
| | Body Weight | 2 | 2004 | 523 | 0.060 |
Why?
| | Leiomyosarcoma | 1 | 2005 | 21 | 0.060 |
Why?
| | Europe | 1 | 2025 | 87 | 0.060 |
Why?
| | Fossil Fuels | 1 | 2024 | 1 | 0.060 |
Why?
| | Ultrasonography | 4 | 2009 | 430 | 0.060 |
Why?
| | Aircraft | 1 | 2004 | 8 | 0.060 |
Why?
| | Diet | 1 | 2009 | 587 | 0.060 |
Why?
| | Twins, Monozygotic | 1 | 2024 | 16 | 0.060 |
Why?
| | Watchful Waiting | 1 | 2024 | 28 | 0.060 |
Why?
| | Play and Playthings | 1 | 2004 | 14 | 0.060 |
Why?
| | Costs and Cost Analysis | 1 | 2004 | 95 | 0.060 |
Why?
| | Organothiophosphorus Compounds | 1 | 2004 | 6 | 0.060 |
Why?
| | Firearms | 1 | 2004 | 19 | 0.060 |
Why?
| | Insecticides | 1 | 2004 | 17 | 0.050 |
Why?
| | Wounds, Gunshot | 1 | 2004 | 33 | 0.050 |
Why?
| | Water Movements | 1 | 2003 | 2 | 0.050 |
Why?
| | Healthy People Programs | 1 | 2003 | 4 | 0.050 |
Why?
| | Carcinoma | 1 | 2025 | 138 | 0.050 |
Why?
| | Social Change | 1 | 2003 | 5 | 0.050 |
Why?
| | Automobiles | 1 | 2003 | 13 | 0.050 |
Why?
| | Waste Disposal, Fluid | 1 | 2003 | 6 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 3 | 2025 | 1546 | 0.050 |
Why?
| | Rectal Diseases | 1 | 2003 | 11 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2004 | 404 | 0.050 |
Why?
| | Digestive System Surgical Procedures | 1 | 2003 | 32 | 0.050 |
Why?
| | Eukaryotic Initiation Factor-4A | 1 | 2002 | 1 | 0.050 |
Why?
| | Prokaryotic Cells | 1 | 2002 | 2 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2025 | 1165 | 0.050 |
Why?
| | Defective Viruses | 1 | 2002 | 1 | 0.050 |
Why?
| | Cost of Illness | 1 | 2003 | 121 | 0.050 |
Why?
| | Gastroschisis | 1 | 2003 | 39 | 0.050 |
Why?
| | GATA6 Transcription Factor | 1 | 2022 | 3 | 0.050 |
Why?
| | GATA4 Transcription Factor | 1 | 2022 | 11 | 0.050 |
Why?
| | Genetic Engineering | 1 | 2002 | 23 | 0.050 |
Why?
| | Hydrochloric Acid | 1 | 2002 | 2 | 0.050 |
Why?
| | Risk Factors | 3 | 2021 | 3889 | 0.050 |
Why?
| | Citric Acid | 1 | 2002 | 17 | 0.050 |
Why?
| | Disease Reservoirs | 1 | 2002 | 3 | 0.050 |
Why?
| | Magnetic Phenomena | 1 | 2022 | 5 | 0.050 |
Why?
| | Occupations | 1 | 2002 | 18 | 0.050 |
Why?
| | Pancreas | 1 | 2022 | 71 | 0.050 |
Why?
| | Gels | 1 | 2022 | 22 | 0.050 |
Why?
| | Fibrin | 1 | 2002 | 10 | 0.050 |
Why?
| | Empyema | 1 | 2002 | 4 | 0.050 |
Why?
| | Length of Stay | 4 | 2008 | 663 | 0.050 |
Why?
| | Republic of Belarus | 1 | 2002 | 1 | 0.050 |
Why?
| | Intelligence | 1 | 2002 | 52 | 0.050 |
Why?
| | Russia | 1 | 2002 | 10 | 0.050 |
Why?
| | Ukraine | 1 | 2002 | 6 | 0.050 |
Why?
| | Deficiency Diseases | 1 | 2002 | 13 | 0.050 |
Why?
| | Reference Values | 3 | 2008 | 313 | 0.050 |
Why?
| | Hepacivirus | 1 | 2002 | 106 | 0.050 |
Why?
| | Drug Resistance, Bacterial | 1 | 2002 | 82 | 0.050 |
Why?
| | State Medicine | 1 | 2021 | 17 | 0.050 |
Why?
| | Critical Pathways | 1 | 2002 | 35 | 0.050 |
Why?
| | Cross Infection | 1 | 2002 | 93 | 0.050 |
Why?
| | Thyroid Gland | 1 | 2002 | 78 | 0.050 |
Why?
| | Forecasting | 1 | 2002 | 154 | 0.050 |
Why?
| | Bacterial Infections | 1 | 2002 | 101 | 0.050 |
Why?
| | Incidence | 3 | 2013 | 1062 | 0.050 |
Why?
| | Intestines | 1 | 2002 | 154 | 0.050 |
Why?
| | Sensitivity and Specificity | 3 | 2008 | 891 | 0.050 |
Why?
| | Smoking | 1 | 2005 | 520 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2002 | 267 | 0.040 |
Why?
| | Congenital Abnormalities | 1 | 2002 | 118 | 0.040 |
Why?
| | Thyroid Neoplasms | 1 | 2002 | 116 | 0.040 |
Why?
| | Proteins | 1 | 2003 | 348 | 0.040 |
Why?
| | RNA | 2 | 2012 | 168 | 0.040 |
Why?
| | Acetaminophen | 1 | 2022 | 279 | 0.040 |
Why?
| | Mice | 4 | 2011 | 5949 | 0.040 |
Why?
| | Sepsis | 1 | 2002 | 239 | 0.040 |
Why?
| | Radiography | 2 | 2009 | 470 | 0.040 |
Why?
| | Probability | 2 | 2008 | 172 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2022 | 1105 | 0.030 |
Why?
| | Intestinal Mucosa | 2 | 2009 | 224 | 0.030 |
Why?
| | Pregnancy | 1 | 2024 | 2680 | 0.030 |
Why?
| | Arkansas | 3 | 2010 | 2028 | 0.030 |
Why?
| | Young Adult | 2 | 2017 | 4329 | 0.030 |
Why?
| | Injury Severity Score | 2 | 2008 | 167 | 0.030 |
Why?
| | Colon | 2 | 2009 | 104 | 0.030 |
Why?
| | Models, Animal | 2 | 2009 | 234 | 0.030 |
Why?
| | Los Angeles | 1 | 2015 | 31 | 0.030 |
Why?
| | Reoperation | 2 | 2008 | 465 | 0.030 |
Why?
| | Sex Factors | 2 | 2008 | 727 | 0.030 |
Why?
| | Data Collection | 1 | 2015 | 290 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2009 | 1478 | 0.030 |
Why?
| | ROC Curve | 1 | 2013 | 253 | 0.030 |
Why?
| | Mutagenesis | 2 | 2003 | 61 | 0.020 |
Why?
| | Age Factors | 2 | 2008 | 1132 | 0.020 |
Why?
| | Staphylococcus epidermidis | 2 | 2002 | 18 | 0.020 |
Why?
| | Planning Techniques | 1 | 2012 | 8 | 0.020 |
Why?
| | Automobile Driving | 1 | 2012 | 27 | 0.020 |
Why?
| | Exons | 1 | 2012 | 102 | 0.020 |
Why?
| | California | 1 | 2012 | 90 | 0.020 |
Why?
| | Health Plan Implementation | 1 | 2012 | 38 | 0.020 |
Why?
| | Social Class | 1 | 2012 | 94 | 0.020 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2011 | 49 | 0.020 |
Why?
| | Micrococcal Nuclease | 1 | 2011 | 7 | 0.020 |
Why?
| | RNA-Induced Silencing Complex | 1 | 2011 | 2 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-3 | 1 | 2011 | 1 | 0.020 |
Why?
| | RNA, Ribosomal | 1 | 2011 | 18 | 0.020 |
Why?
| | Oligonucleotides, Antisense | 1 | 2011 | 30 | 0.020 |
Why?
| | Nucleotide Motifs | 1 | 2011 | 23 | 0.020 |
Why?
| | Logistic Models | 1 | 2013 | 925 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2011 | 76 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2015 | 509 | 0.020 |
Why?
| | Silicon | 1 | 2010 | 9 | 0.020 |
Why?
| | Immunoassay | 1 | 2010 | 23 | 0.020 |
Why?
| | Edeine | 1 | 2009 | 1 | 0.020 |
Why?
| | RNA, Complementary | 1 | 2009 | 2 | 0.020 |
Why?
| | 5' Flanking Region | 1 | 2009 | 7 | 0.020 |
Why?
| | Diatrizoate Meglumine | 1 | 2009 | 2 | 0.020 |
Why?
| | Nucleotides | 1 | 2009 | 24 | 0.020 |
Why?
| | Luciferases | 1 | 2009 | 48 | 0.020 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2009 | 42 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2011 | 176 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2009 | 17 | 0.020 |
Why?
| | Phenotype | 2 | 2003 | 789 | 0.020 |
Why?
| | Chronic Disease | 1 | 2012 | 586 | 0.020 |
Why?
| | Hirschsprung Disease | 1 | 2009 | 2 | 0.020 |
Why?
| | Neurons | 2 | 2003 | 418 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 88 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2009 | 68 | 0.020 |
Why?
| | Birth Weight | 1 | 2009 | 125 | 0.020 |
Why?
| | Staff Development | 1 | 2009 | 24 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2010 | 185 | 0.020 |
Why?
| | Cecum | 1 | 2009 | 61 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 178 | 0.020 |
Why?
| | Peritonitis | 1 | 2008 | 27 | 0.020 |
Why?
| | Foreign-Body Migration | 1 | 2008 | 31 | 0.020 |
Why?
| | Physical Examination | 1 | 2009 | 99 | 0.020 |
Why?
| | Pelvis | 1 | 2008 | 69 | 0.020 |
Why?
| | Preoperative Care | 1 | 2009 | 173 | 0.020 |
Why?
| | Phenoxybenzamine | 1 | 2008 | 18 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 673 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2008 | 28 | 0.020 |
Why?
| | Phosphorylation | 1 | 2009 | 528 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2009 | 144 | 0.020 |
Why?
| | Sex Distribution | 1 | 2008 | 137 | 0.020 |
Why?
| | Radiography, Abdominal | 1 | 2008 | 25 | 0.020 |
Why?
| | Adrenalectomy | 1 | 2008 | 31 | 0.020 |
Why?
| | Age Distribution | 1 | 2008 | 174 | 0.020 |
Why?
| | Intestinal Volvulus | 1 | 2007 | 6 | 0.020 |
Why?
| | Colony Count, Microbial | 1 | 2008 | 63 | 0.020 |
Why?
| | Gestational Age | 1 | 2009 | 417 | 0.020 |
Why?
| | Interprofessional Relations | 1 | 2009 | 90 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 208 | 0.020 |
Why?
| | Neurosurgery | 1 | 2008 | 36 | 0.020 |
Why?
| | General Surgery | 1 | 2009 | 105 | 0.020 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2008 | 38 | 0.020 |
Why?
| | Safety | 1 | 2008 | 79 | 0.020 |
Why?
| | Nurse's Role | 1 | 2008 | 70 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2008 | 183 | 0.020 |
Why?
| | Horseradish Peroxidase | 1 | 2007 | 17 | 0.020 |
Why?
| | Postoperative Care | 1 | 2008 | 104 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2007 | 288 | 0.020 |
Why?
| | Random Allocation | 1 | 2008 | 285 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2009 | 258 | 0.020 |
Why?
| | Carbohydrates | 1 | 2007 | 41 | 0.020 |
Why?
| | Angioplasty | 1 | 2006 | 20 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2008 | 243 | 0.020 |
Why?
| | Kidney Failure, Chronic | 1 | 2008 | 210 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2007 | 120 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2008 | 639 | 0.020 |
Why?
| | Gene Expression | 1 | 2008 | 618 | 0.020 |
Why?
| | Survival Rate | 1 | 2008 | 945 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 2006 | 278 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2008 | 772 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2009 | 1229 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 979 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2008 | 488 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2008 | 1201 | 0.010 |
Why?
| | Glucose | 1 | 2007 | 355 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2008 | 1026 | 0.010 |
Why?
| | Algorithms | 1 | 2007 | 672 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2004 | 171 | 0.010 |
Why?
| | Creatinine | 1 | 2004 | 150 | 0.010 |
Why?
| | Rectal Fistula | 1 | 2003 | 1 | 0.010 |
Why?
| | Congresses as Topic | 1 | 2003 | 48 | 0.010 |
Why?
| | Housing | 1 | 2003 | 49 | 0.010 |
Why?
| | Compartment Syndromes | 1 | 2003 | 17 | 0.010 |
Why?
| | Internship and Residency | 1 | 2009 | 448 | 0.010 |
Why?
| | Apoptotic Protease-Activating Factor 1 | 1 | 2003 | 1 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 96 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 2003 | 50 | 0.010 |
Why?
| | Cysts | 1 | 2003 | 51 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2002 | 57 | 0.010 |
Why?
| | Enterobacter | 1 | 2002 | 6 | 0.010 |
Why?
| | Vancomycin Resistance | 1 | 2002 | 6 | 0.010 |
Why?
| | Enterococcus | 1 | 2002 | 9 | 0.010 |
Why?
| | Neuroblastoma | 1 | 2002 | 51 | 0.010 |
Why?
| | Methicillin Resistance | 1 | 2002 | 17 | 0.010 |
Why?
| | Disease Transmission, Infectious | 1 | 2002 | 12 | 0.010 |
Why?
| | Protein Conformation | 1 | 2003 | 176 | 0.010 |
Why?
| | Food Contamination | 1 | 2002 | 37 | 0.010 |
Why?
| | Venous Cutdown | 1 | 2002 | 1 | 0.010 |
Why?
| | Subclavian Vein | 1 | 2002 | 10 | 0.010 |
Why?
| | Bacterial Adhesion | 1 | 2002 | 16 | 0.010 |
Why?
| | Transfection | 1 | 2003 | 357 | 0.010 |
Why?
| | Thoracostomy | 1 | 2002 | 10 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2006 | 649 | 0.010 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2002 | 11 | 0.010 |
Why?
| | Health Status | 1 | 2003 | 294 | 0.010 |
Why?
| | Gene Deletion | 1 | 2003 | 272 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2002 | 460 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2003 | 461 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 582 | 0.010 |
Why?
| | Blotting, Western | 1 | 2003 | 590 | 0.010 |
Why?
| | Equipment Design | 1 | 2002 | 293 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 1378 | 0.010 |
Why?
| | Staphylococcus aureus | 1 | 2002 | 338 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2002 | 1563 | 0.010 |
Why?
| | Rats | 1 | 2002 | 3220 | 0.010 |
Why?
|
|
Jackson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|